Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Drug control --- Drug abuse --- -Pharmaceutical policy --- -Drug policy --- Drugs --- Drugs and state --- Pharmacy --- Pharmacy and state --- State and drugs --- State and pharmacy --- Medical policy --- Drug use --- Recreational drug use --- Substance abuse --- Great Britain --- -Prevention --- Government policy --- Pharmaceutical policy --- Prevention. --- -Great Britain --- Drug policy --- Great Britain&delete& --- Prevention

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book applies an established analytical framework for health sector reform (Getting Health Reform Right, Oxford, 2004) to the performance problems of the pharmaceutical sector. The book is divided into three sections. The first section presents the basic ideas for analysis. It begins by insisting that reform start with a clear understanding of the performance deficiencies of the current system. Like all priority setting in the public sector, this 'definition of the problem' involves both ethical choices and political processes. Early chapters explain the foundations of these ideas and appl

Pharmaceutical policy. --- Pharmaceutical industry. --- Health care reform. --- Health reform --- Health system reform --- Healthcare reform --- Medical care reform --- Reform of health care delivery --- Reform of medical care delivery --- Drug industry --- Drug trade --- Drug policy --- Drugs --- Drugs and state --- Pharmacy --- Pharmacy and state --- State and drugs --- State and pharmacy --- Government policy --- Medical policy --- Health insurance --- Medicine industry --- Medicines industry --- Prescription medicine industry --- Chemical industry

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This title examines the tension between intellectual property law and access to medicine in a set of developing countries caught between their international trade obligations and their commitment to the health of their citizens.

Pharmaceutical policy --- Drug accessibility --- Drugs --- Conflict of laws --- Intellectual property --- Choice of law --- Intermunicipal law --- International law, Private --- International private law --- Private international law --- Law --- Legal polycentricity --- Access to drugs --- Accessibility of drugs --- Availability of drugs --- Drug availability --- Drug policy --- Drugs and state --- Pharmacy --- Pharmacy and state --- State and drugs --- State and pharmacy --- Medical policy --- Civil law --- Government policy

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Every four minutes, over 50 children under the age of five die. In the same four minutes, 2 mothers lose their lives in childbirth. Every year, malaria kills nearly 1.2 million people, despite the fact that it can be prevented with a mosquito net and treated for less than 1.50.Sadly, this list goes on and on. Millions are dying from diseases that we can easily and inexpensively prevent, diagnose, and treat. Why? Because even though we know exactly what people need, we just can't get it to them. They are dying not because we can't solve a medical problem but because we can't solve a logistics

Pharmaceutical policy --- Drugs --- Medical care --- World health. --- Global health --- International health --- Public health --- Medical geography --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Pharmacy --- Drug policy --- Drugs and state --- Pharmacy and state --- State and drugs --- State and pharmacy --- Medical policy --- International cooperation --- Government policy --- World health --- E-books

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.

Pharmaceutical policy. --- Patent laws and legislation. --- Drugs --- Patents (International law) --- Drug policy --- Drugs and state --- Pharmacy --- Pharmacy and state --- State and drugs --- State and pharmacy --- Medical policy --- Patent laws and legislation (International law) --- International law --- Law, Patent --- Patents --- Scientific property --- Industrial laws and legislation --- Industrial property --- Trade regulation --- Copyright --- Government policy --- Law and legislation --- Patents. --- Law --- General and Others